Are you treating with the superoxide dismutase mimetic Avasopasem (GC4419) for patients receiving chemoradiation for head & neck cancers?
After the randomized Phase IIb showed decreased mucositis, are you incorporating this agent? Please share your regimen and any tips.
Community PollStarted
Are you adding Avasopasem when treating head & neck cancers with chemoradiation?
22 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · University of Iowa
Answered on
This drug is not yet FDA-approved. It is currently under review by the FDA. I plan to use it after it is approved.
Join for free or sign in to see the full answer